HEALTH & LIFE SCIENCES NEWS
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries

McDermott Will & Emery

Subscribe to McDermott Will & Emery's Posts

After the Curve Podcast: Focus on Health Insurance and Coverage


By on Nov 10, 2020
Posted In Digital Health, Hospitals & Health Systems

COVID-19 has catalyzed significant changes in the patterns of healthcare delivery, with the potential for long lasting effects on payors as a result. On this episode of the After the Curve podcast, we discuss how the COVID-19 pandemic may shift the healthcare coverage and payment landscape as well as how it may boost integration among...

Continue Reading



After the Curve Podcast: Focus on Transactions


By on Oct 20, 2020
Posted In Health M&A

The lasting impact of COVID-19 on healthcare transactions is multifaceted and has rapidly altered the trajectory of the dealmaking landscape as well as business collaborations. On this episode of the After the Curve podcast, we discuss how the COVID-19 pandemic is affecting healthcare transactions today, as well as the outlook for the healthcare deal landscape...

Continue Reading



After the Curve Podcast: Focus on Regulatory and Enforcement


By on Oct 15, 2020
Posted In Hospitals & Health Systems

COVID-19 led to major policy changes impacting how healthcare is delivered and reimbursed but only some of these new policies will endure in coming years. On this episode of the After the Curve Podcast, we discuss how the regulatory landscape and enforcement priorities may shift in both the short and long term as we transition...

Continue Reading



After the Curve Podcast: Focus on Providers


By on Oct 13, 2020
Posted In Hospitals & Health Systems

COVID-19 led to major policy changes impacting how healthcare is delivered and reimbursed but only some of these new policies will endure in the coming years. On this episode of the After the Curve Podcast, we discuss how provider organizations can innovate their business models and care delivery to adapt and thrive in a post-COVID-19...

Continue Reading



After the Curve Podcast: Focus on Life Sciences


By on Oct 8, 2020
Posted In Life Sciences

In this time of crisis, the life science industry has demonstrated remarkable speed, innovation and resilience. In this episode of the After the Curve podcast, our life sciences partners join us to discuss the most promising areas of drug discovery and device development that are emerging from the pandemic and the outlook for the industry...

Continue Reading



After the Curve Podcast: Focus on Health Policy


By on Oct 6, 2020
Posted In Hospitals & Health Systems, Uncategorized

COVID-19 led to major policy changes impacting how healthcare is delivered and reimbursed, but only some of these new policies will endure in coming years. On this episode of the After the Curve podcast, our colleagues from McDermott+Consulting join us to discuss how the pandemic has changed the conversation leading up to the November presidential...

Continue Reading



5 Questions with a Health Lawyer: Steven J. Schnelle


By on Sep 17, 2020
Posted In Uncategorized

Steven J. Schnelle Practice Focus Area: Healthcare Office: New York Years at Firm: 2.5 years What is your favorite part about practicing healthcare law at McDermott? Without a doubt, the people! Every day I have the pleasure and honor of working with brilliant and unique colleagues that recognize and appreciate one another’s contributions to our...

Continue Reading



Public Hospital M&A: Know Your Stakeholders


By on Aug 24, 2020
Posted In Health M&A, Hospitals & Health Systems, Tax-Exempt

Hospital transactional activity has soared over the last decade, and many public hospitals are evaluating M&A opportunities against the backdrop of the Coronavirus (COVID-19) pandemic. In our previous post on public hospital M&A, we discussed financial pressures on public hospitals, trends driving M&A, and external factors shaping public hospitals’ choices of M&A partners and formats....

Continue Reading



5 Questions with a Health Policy Specialist: Rodney L. Whitlock of McDermott+Consulting


By on Aug 20, 2020
Posted In Uncategorized

Rodney L. Whitlock, Ph.D Vice President, McDermott+Consulting Focus Area: Healthcare Policy Years at M+: 1.5 years What is your favorite part about your health policy work at McDermott+Consulting? Healthcare policy, politics and process is complicated. It is a constant challenge to discern and anticipate the future of healthcare policy for clients. It is the constant...

Continue Reading



European Healthcare Innovation & Investment in a Post-Pandemic World


By on Jul 6, 2020
Posted In Digital Health, Health M&A, Health Private Equity, Hospitals & Health Systems, International Health

As part of McDermott’s HPE Europe 2020: Where Do the Opportunities Exist for Investment in the Healthcare Sector? webinar, McDermott London Managing Partner Hamid Yunis moderated a panel of industry experts including; Dr. Michelle Tempest of Candesic, Dr. Joanne Hackett of IZY Capital, Dr. Charles Niehaus and Professor Karol Sikora of Rutherford Cancer Centres, who...

Continue Reading



STAY CONNECTED

TOPICS

ARCHIVES

Chambers 2021 Top Ranked
U.S. News Law Firm of the Year 2022 Health Care Law
LEgal 500 EMEA top tier firm 2021
Legal 500 USA top tier firm